Pseudomonas Infections

06/01/2012 - "Antibiotics are effective in preventing morbidity and mortality from Pseudomonas infection, but because of spreading multidrug-resistant bacterial strains, bacteriophages are being explored as an alternative therapy. "
01/01/2012 - "He had increasing frequency of admission due to methicillin-resistant Staphylococcus aureus and pseudomonas infections, which failed to clear despite intravenous, prolonged oral and nebulised antibiotics. "
05/01/2007 - "One week following control of the condition with antibiotics, a 1 x 1-cm, red, painful nodule appeared on the left thigh, which was initially suspected to be Pseudomonas infection. "
03/01/2007 - "For these reasons, patients with Pseudomonas infection might receive empirical antibiotics that are inactive against Pseudomonas, especially before antibiotic susceptibility results become available. "
12/01/1997 - "MICs for some strains were lowered to clinically achievable levels of the antibiotics, which is compatible with impressions of greater clinical efficacy in pseudomonas infections than would be predicted by standard sensitivity tests. "

04/01/1989 - "[Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection]."
08/01/2008 - "Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: a pilot project."
04/01/1976 - "Treatment of pseudomonas infections in cystic fibrosis using tobramycin."
12/01/1981 - "In this double-masked study involving 66 patients, the two aminoglycosides were found to be equally safe and effective, although the in vitro data suggested that tobramycin may be more efficacious against Pseudomonas infections. "
04/01/2008 - "In a large, randomized clinical trial, addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas infection produced microbiologic improvement correlating with clinical outcomes but not overall improvement. "

04/09/1983 - "A gentamicin-containing steroid ointment was effective against the Pseudomonas infection."
01/01/2012 - "These data highlight that the controlled release of gentamicin may be applicable for treating Pseudomonas infections."
01/01/2012 - "Gentamicin is an aminoglycoside antibiotic commonly used for treating Pseudomonas infections, but its use is limited by a relatively short half-life. "
07/01/1999 - "The treatment success rates were 74.0% if pseudomonas infections were excluded, 76.1% if gentamicin-resistant pathogens were excluded, and 80.5% if both pseudomonas infections and gentamicin-resistant pathogens were excluded. "
09/01/1989 - "Undefined factors other than inactivation of gentamicin may be responsible for the lack of bactericidal activity and treatment failure of Pseudomonas infections."

01/01/1979 - "In 16 patients with serious Pseudomonas infections of the respiratory tract the good efficacy of azlocillin was shown. "
05/01/1983 - "A pharmacokinetic and clinical study was done in 25 newborn infants suffering predominantly from pseudomonas infections treated with azlocillin. "
05/01/1983 - "Treatment of serious Pseudomonas infections with azlocillin."
09/01/1980 - "39 children were treated with azlocillin, 35 of whom had Pseudomonas infection. "
01/01/1979 - "Pseudomonas infections of the lung treated with azlocillin. "

10/01/2007 - "If avoidance of aminoglycosides in patients testing positive leads to an absolute increase in the lifetime risk of death from Pseudomonas infection of 0.8% or greater, A1555G testing would lead to a decrease in quality-adjusted life-years. "
12/01/1981 - "In this double-masked study involving 66 patients, the two aminoglycosides were found to be equally safe and effective, although the in vitro data suggested that tobramycin may be more efficacious against Pseudomonas infections. "
10/01/1993 - "The clinical use of aminoglycosides has somewhat decreased over the last decade because of the introduction of the less toxic cephalosporins of the third generation and the quinolones, which are effective against Pseudomonas infections. "
01/01/1992 - "The problem of the resistance to fluoroquinolones, which can develop more frequently during treatment of Staphylococcus and Pseudomonas infection, and the possibility of preventing bacterial resistance through concurrent therapy with other antimicrobial agents such as aminoglycosides are also discussed. "
07/28/1986 - "For Pseudomonas infections, ticarcillin, carbenicillin, the ureidopenicillins, and the aminoglycosides are indicated. "

10/01/1989 - "Studies using either higher dosages of ciprofloxacin or combination therapy should be conducted to determine if acquired resistance can be avoided in Pseudomonas infections."
04/01/2014 - "Pseudomonas infections of the nail organ are treated by ciprofloxacin; other bacteria are treated according to the results of culture and sensitivity testing."
04/15/2010 - "At present time Ciprofloxacin is relatively effective antibiotic for Pseudomonas infection. "
01/01/2004 - "Ciprofloxacin treatment in newborns with multi-drug-resistant nosocomial Pseudomonas infections."
12/01/2015 - "A total of 41 children with CF aged 2-14 years, without chronic Pseudomonas infection, were randomized to receive ciprofloxacin (n = 28) or placebo (n = 13) at the onset of acute viral respiratory infections on an intention to treat basis, during a study period of up to 32 months. "

06/01/1984 - "On the basis of sensitivity testing, carbenicillin was used to treat nine snakes of four different species, with confirmed Pseudomonas infections. "
07/01/1978 - "Carbenicillin can be used in Pseudomonas infections and is characterized by its low toxicity. "
10/04/1971 - "Carbenicillin therapy for pseudomonas infections."
11/21/1970 - "Carbenicillin in pseudomonas infections."
10/31/1970 - "Carbenicillin in pseudomonas infections."

10/26/1988 - "As regards ceftazidime, they have confirmed that its activity is time-dependent in vivo, that there is no post-antibiotic effect and that combining this cephalosporin with an aminoglycoside is useful in neutropenic animals, notably in case of Pseudomonas infection. "
03/01/1986 - "Ceftazidime in patients with severe Pseudomonas infections."
07/01/1983 - "Ceftazidime in patients with Pseudomonas infections."
09/01/1986 - "Ceftazidime in the treatment of Pseudomonas infections in intensive-care patients."
07/01/1983 - "Of 541 pseudomonas infections (all sites) treated with ceftazidime 60% cleared and 40% relapsed or failed; of 76 infections treated with other agents 43% cleared and 57% relapsed or failed. "

02/01/1978 - "The protective effects of SCE-129 on Pseudomonas infection in mice varied according to the dosage schedule and the challenge dose. "
11/01/1982 - "[Clinical application of cefsulodin in gravely ill children with Pseudomonas infection]."
11/01/1982 - "[Clinical evaluation of cefsulodin in Pseudomonas infections in children]."
10/31/1981 - "[Treatment of Pseudomonas infections in children with cefsulodin (author's transl)]."
11/01/1982 - "1. Cefsulodin (CFS) was administered intravenously by one shot or drip infusion in 3 patients with Pseudomonas infections. "

06/16/1978 - "Tobramycin is more effective than gentamicin and sisomicin against Pseudomonas infections. "
12/01/1978 - "Comparison of 5-episisomicin (Sch 22591), gentamicin, sisomicin, and tobramycin in treatment of experimental Pseudomonas infections in mice."
09/01/1976 - "These in vitro results suggest that tobramycin, sisomicin, or amikacin in combination with carbenicillin would be the safest initial regimen in the therapy of gentamicin-resistant Pseudomonas infections pending susceptibility studies."

05/01/2013 - "In addition, our research data indicate that risk factors such as use of ventilator, use of antimicrobials and ICU hospitalization can be effective in managing Pseudomonas infection."
09/01/2009 - "We report a case of Pott's puffy tumor (PPT) with Pseudomonas infection occurring after acupuncture therapy in a ventilator-dependent child. "

11/01/1999 - "Delayed-onset of Pseudomonas infection in a hydroxyapatite orbital implant: a case report."

03/01/2015 - "Transition to death from transplant was facilitated by pseudomonas infection and single lung transplant. "
03/01/2013 - "Movement from transplant to death was facilitated by pseudomonas infection and single lung transplant. "
09/01/2007 - "Moreover, the CF lung transplant patients had significantly less time free from Pseudomonas infections. "
05/01/2001 - "In contrast to earlier studies, an exposed anastomosis, interval to infection, or Pseudomonas infection is not associated with graft failure. "
10/01/2012 - "We describe the first reported case of a mycotic pseudoaneurysm of the descending thoracic aorta related to the remnant of a left ventricular assist device outflow graft in an immunosuppressed heart recipient complicated with systemic Pseudomonas infection. "

01/01/2013 - "These results are also relevant in the context of drug therapy, since ClpP and Lon are good candidates to become novel therapeutic targets to combat Pseudomonas infections."
12/10/1990 - "[Drug therapy of intractable Pseudomonas infections]."
08/30/1968 - "[Chemotherapy of Pseudomonas infections in severely burned patients. "
08/01/1967 - "[Chemotherapy for Pseudomonas infections]."
08/01/1967 - "[Chemotherapy for Pseudomonas infections]."

01/01/1998 - "presence of vascular catheter) or Pseudomonas infection (e.g. "
01/01/2007 - "Considering the encouraging results obtained on Pseudomonas infection, we decided to utilize the same schedule for the treatment of exit-site infections caused by other germs which are generally difficult to eradicate to prevent peritonitis and catheter removal. "
01/01/1993 - "Both removal of the peritoneal catheter and death as consequences of CAPD peritonitis are associated with malnutrition and pseudomonas infection. "
01/01/2007 - "Successful use of sodium hypochlorite pack plus systemic and local antibiotic therapy for the treatment of pseudomonas infection of peritoneal dialysis catheter exit-site."